PBT2 from the Doherty Institute news site., page-21

First 21 Last

Share
Profile

Follow
johnmartin

69 Posts.

1

22/02/19

17:45

Post #: 37536045
Share

Originally posted by gumboot ↑

Originally posted by pivalde
My e-mail on Feb 3rd: ......."
..... there is now the Sinclair deal pending and there is this kind of very valuable paper already published I want that Prana to know this new paper".

To me the answer indicated that Prana had no info about the results. I wrote to Prana but usually you do not get any report from their general e-mail. That is why I phoned to Prana on 4th of Feb ( early in European time) and Ms Rowe in Prana asked me to send the e-mail to her. This is what I sent:
Dear Ms Rowe

Thank you for your help. I send you now the abstract about the study using PBT2 against dangerous bacteria. Please send it to Mr. Kempler and to Dr. Stamler.

This paper below is worth of millions to Prana !

Yours sincerely

She got my e-mail and most likely sent it as promised. So I sent the info to 3 different places in Prana.

So Prana has known this PBT2 paper only for 17 days. A lot to get shorted : patent, co-oper agreement with universities, with Sinclair group, with Big antibiotic companies etc. Hope it is not too much for a small company.
The paper was published online on Dec 11 and widely commented on subsequently.
If Sir Humphrey of Yes Prime Minister was advising the individials of the board and management he would describe their supposed ignorance as "courageous"..
Perhaps their business course on market sensitive information was given by Sergeant Schultz

Expand

This is ridiculous. Has anyone else had any reply from Prana. We should of heard something by now. Any shareholders live in Melbourne need to go to head office and find out what the $&@“ is going on. Thanks for all your great posts skint, pivalde, headset and the rest of you. Hopefully we get some news next week if not more phone calls emails and a possible head office visit in order. Good luck to all the shareholders

PBT Price at posting: 3.9¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

AXP

Tambourah chases gold veins and mineralisation extension with drilling

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 21 more messages in this thread...

First 21 Last

Add PBT (ASX) to my watchlist

PBT2 from the Doherty Institute news site., page-21

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Tambourah chases gold veins and mineralisation extension with drilling

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Featured News